PDCD1与CTLA4基因多态性影响慢性免疫性血小板减少症的易感性及临床特征
研究纳入119例慢性免疫性血小板减少症(cITP)患者与223例健康对照,用PCR-RFLP法检测PDCD1与CTLA4单核苷酸多态性。cITP患者PDCD1 +7209 TT基因型频率显著高于对照;CTLA4 -1577 GG与CT60 GG基因型与诊断时血小板<5×10^9/L、最低血小板<5×10^9/L及出血症状比例更高相关;PDCD1 -606 AA与+63379 TT基因型与泼尼松龙完全缓解人数更少显著相关。
要点
- cITP患者PDCD1 +7209 TT基因型频率显著高于健康对照。
- CTLA4 -1577 GG与CT60 GG基因型者血小板<5×10^9/L及出血症状比例更高。
- PDCD1 -606 AA与+63379 TT基因型者泼尼松龙完全缓解人数显著更少。
核心结论
- 免疫检查点基因多态性可能影响cITP的易感性、临床特征及患者治疗反应。
研究设计与样本
- 病例对照研究,纳入119例cITP患者与223例健康对照,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)法测定基因型。
主要发现
- cITP患者PDCD1 +7209 TT基因型频率显著高于健康对照。
- CTLA4 -1577 GG基因型与CT60 GG基因型者诊断时血小板计数<5×10^9/L、最低血小板计数<5×10^9/L及出血症状的频率更高。
- PDCD1 -606 AA基因型与+63379 TT基因型与泼尼松龙治疗后达到完全缓解的患者人数更少显著相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Programmed death-1 (PD-1, PDCD1) and cytotoxic T lymphocyte-associated antigen-4 (CTLA-4, CTLA4) play central roles in immune checkpoint pathways. Single nucleotide polymorphisms (SNPs) of PDCD1 and CTLA4 have been reported to be associated with susceptibility to some autoimmune diseases. However, the potential association between SNPs in these immune checkpoint genes and risk of chronic immune thrombocytopenia (cITP) remain controversial and obscure. The aims of this study were to clarify the influence of PDCD1 and CTLA4 SNPs on the risk of developing cITP and its clinical features. We obtained genomic DNA from 119 patients with cITP and 223 healthy controls; their genotypes were determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Patients with cITP had a significantly higher frequency of the PDCD1 +7209 TT genotype compared with healthy controls. The CTLA4 -1577 GG genotype and CT60 GG genotype showed higher frequencies of platelet count <5 × 109 /l at diagnosis, minimum platelet count <5 × 109 /l, and bleeding symptoms. Moreover, the PDCD1 -606 AA genotype and +63379 TT genotype were significantly associated with a lower number of patients who achieved a complete response to prednisolone treatment. Our results suggest that the immune checkpoint polymorphisms may affect the susceptibility to the clinical features of cITP, and treatment response of the affected patients.
引用
- Kasamatsu T, Ino R, Takahashi N, et al. PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia. Br J Haematol. 2018. PMID: 29359792. doi:10.1111/bjh.15085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。